Expression of RPL13 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL13 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2269.86

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

1885.3

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	3757.0
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	3597.2
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	3301.7
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	3285.8
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	3247.3
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	3108.8
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	2954.3
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	2938.5
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	2930.7
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2845.9
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	2722.3
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	2697.0
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	2682.2
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	2645.5
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	2632.8
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	2589.2
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	2550.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	2526.5
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	2512.1
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	2489.1
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	2423.7
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	2422.3
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	2400.4
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	2382.4
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2373.9
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2369.8
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2344.5
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	2335.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	2312.9
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	2269.9
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2261.1
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	2260.7
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	2202.7
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	2202.0
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2184.6
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	2160.7
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2160.6
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2140.7
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	2132.7
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2106.1
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	2092.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2067.1
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	2043.7
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	2039.0
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2038.1
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	2035.0
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	2030.3
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	2028.9
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	2026.1
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	2011.2
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2007.6
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1998.1
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	1963.9
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	1960.1
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	1928.6
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1881.5
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	1878.0
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	1850.4
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	1845.1
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	1844.2
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1821.2
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1819.0
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	1817.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	1797.4
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1796.7
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	1791.9
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1790.7
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	1786.5
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	1785.5
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1770.8
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	1767.4
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1763.2
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1760.5
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1760.3
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1747.5
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	1742.4
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1735.9
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	1735.0
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1729.9
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	1724.7
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	1718.1
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	1716.4
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	1714.3
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	1712.1
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	1712.1
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1703.0
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1693.2
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1686.2
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	1680.3
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	1679.8
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	1675.7
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1669.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	1665.5
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1663.6
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	1644.7
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	1617.0
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1615.1
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	1614.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	1604.9
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	1600.3
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1546.1
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	1533.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	1528.5
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1523.6
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	1506.2
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	1499.2
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	1498.7
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	1492.6
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1489.1
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1464.5
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	1462.6
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	1456.1
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	1446.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	1443.7
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	1425.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1424.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	1400.0
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	1398.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	1383.0
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1378.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	1368.6
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	1364.9
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	1330.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	1318.0
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	1291.2
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1284.9
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	1282.2
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	1274.5
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1250.9
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	1195.6
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1192.4
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1172.7
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1129.7
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1096.2
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	1095.9
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1092.2
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1053.7
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	1013.0
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	994.0
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	950.7
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	916.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL13 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 299.95

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

326.1

Number of samples

Samples

Sample	Description	pTPM
AK213	N, NA, stage:NA, alive, 2010 days	633.3
AK066	N, NA, stage:NA, alive, 960 days	616.9
AK002	N, NA, stage:NA, dead, 570 days	518.7
AK098	N, NA, stage:NA, dead, 660 days	516.4
AK043	N, NA, stage:NA, alive, 660 days	506.8
AK142	N, NA, stage:NA, alive, 90 days	498.2
AK139	N, NA, stage:NA, dead, 270 days	483.5
AK074	N, NA, stage:NA, alive, 300 days	482.6
AK195	N, NA, stage:NA, dead, 390 days	464.0
AK165	N, NA, stage:NA, alive, 360 days	461.0
AK199	N, NA, stage:NA, alive, 1860 days	447.8
AK183	N, NA, stage:NA, alive, 360 days	435.4
AK133	N, NA, stage:NA, dead, 360 days	432.8
AK055	N, NA, stage:NA, dead, 240 days	431.5
AK124	N, NA, stage:NA, alive, 1920 days	407.8
AK088	N, NA, stage:NA, dead, 360 days	385.2
AK185	N, NA, stage:NA, alive, 330 days	382.4
AK178	N, NA, stage:NA, dead, 240 days	380.0
AK051	N, NA, stage:NA, dead, 360 days	379.4
AK053	N, NA, stage:NA, dead, 300 days	375.4
AK049	N, NA, stage:NA, dead, 180 days	359.3
AK068	N, NA, stage:NA, alive, 360 days	349.6
AK134	N, NA, stage:NA, dead, 360 days	344.9
AK041	N, NA, stage:NA, alive, 810 days	340.3
AK188	N, NA, stage:NA, alive, 420 days	338.5
AK071	N, NA, stage:NA, dead, 540 days	306.4
AK015	N, NA, stage:NA, alive, 720 days	301.3
AK236	N, NA, stage:NA, dead, 360 days	298.6
AK205	N, NA, stage:NA, dead, 120 days	290.4
AK158	N, NA, stage:NA, dead, 360 days	285.3
AK149	N, NA, stage:NA, dead, 420 days	278.7
AK079	N, NA, stage:NA, dead, 210 days	273.9
AK231	N, NA, stage:NA, dead, 240 days	272.9
AK091	N, NA, stage:NA, dead, 210 days	270.5
AK100	N, NA, stage:NA, alive, 960 days	264.6
AK072	N, NA, stage:NA, dead, 150 days	264.4
AK117	N, NA, stage:NA, dead, 210 days	259.0
AK123	N, NA, stage:NA, dead, 180 days	247.3
AK089	N, NA, stage:NA, dead, 330 days	246.9
AK173	N, NA, stage:NA, dead, 180 days	246.1
AK153	N, NA, stage:NA, dead, 240 days	241.3
AK218	N, NA, stage:NA, dead, 180 days	236.6
AK216	N, NA, stage:NA, dead, 360 days	235.0
AK167	N, NA, stage:NA, dead, 180 days	233.2
AK156	N, NA, stage:NA, dead, 330 days	226.5
AK099	N, NA, stage:NA, dead, 420 days	223.5
AK102	N, NA, stage:NA, alive, 1740 days	221.5
AK003	N, NA, stage:NA, dead, 600 days	218.0
AK076	N, NA, stage:NA, alive, 660 days	217.3
AK005	N, NA, stage:NA, dead, 240 days	217.1
AK227	N, NA, stage:NA, alive, 300 days	216.1
AK103	N, NA, stage:NA, alive, 1320 days	215.3
AK035	N, NA, stage:NA, dead, 210 days	201.2
AK081	N, NA, stage:NA, dead, 180 days	200.0
AK085	N, NA, stage:NA, alive, 660 days	194.9
AK030	N, NA, stage:NA, dead, 120 days	194.3
AK226	N, NA, stage:NA, dead, 360 days	174.9
AK006	N, NA, stage:NA, dead, 360 days	173.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0182580003	Tumor	1.4
CPT0206560003	Tumor	1.0
CPT0125510003	Tumor	0.9
CPT0219080004	Tumor	0.9
CPT0218330004	Tumor	0.8
CPT0168380003	Tumor	0.7
CPT0190360004	Tumor	0.7
CPT0162020003	Tumor	0.7
CPT0217000004	Tumor	0.7
CPT0125570003	Tumor	0.7
CPT0218690004	Tumor	0.6
CPT0206880003	Tumor	0.6
CPT0208980003	Tumor	0.6
CPT0127480003	Tumor	0.6
CPT0225760003	Tumor	0.5
CPT0217710008	Tumor	0.5
CPT0206230003	Tumor	0.5
CPT0206000004	Tumor	0.4
CPT0168080003	Tumor	0.4
CPT0224390004	Tumor	0.4
CPT0205570003	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0186100003	Tumor	0.3
CPT0218830004	Tumor	0.3
CPT0162100003	Tumor	0.3
CPT0089150003	Tumor	0.3
CPT0206110003	Tumor	0.3
CPT0093450003	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0087950003	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0224540004	Tumor	0.3
CPT0205670004	Tumor	0.3
CPT0217430008	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0093510003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0161730003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0079790003	Tumor	0.2
CPT0171580008	Tumor	0.2
CPT0168830003	Tumor	0.1
CPT0206670004	Tumor	0.1
CPT0221180003	Tumor	0.1
CPT0206450003	Tumor	0.1
CPT0228220003	Tumor	0.0
CPT0078580003	Tumor	0.0
CPT0182550003	Tumor	0.0
CPT0168480003	Tumor	0.0
CPT0064650003	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0087570003	Tumor	0.0
CPT0167530003	Tumor	0.0
CPT0168590003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0225730003	Tumor	-0.1
CPT0002410011	Tumor	-0.1
CPT0071100003	Tumor	-0.1
CPT0087730003	Tumor	-0.1
CPT0093590003	Tumor	-0.1
CPT0207090003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0217880003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0196850003	Tumor	-0.2
CPT0189460003	Tumor	-0.2
CPT0206780003	Tumor	-0.2
CPT0189850004	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0189570004	Tumor	-0.2
CPT0217060003	Tumor	-0.2
CPT0123530003	Tumor	-0.2
CPT0216920008	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0167860004	Tumor	-0.2
CPT0205890003	Tumor	-0.3
CPT0201710003	Tumor	-0.3
CPT0125220003	Tumor	-0.3
CPT0168720003	Tumor	-0.3
CPT0209440003	Tumor	-0.4
CPT0175060003	Tumor	-0.4
CPT0224600003	Tumor	-0.4
CPT0207030003	Tumor	-0.4
CPT0167970003	Tumor	-0.4
CPT0217190003	Tumor	-0.4
CPT0167750004	Tumor	-0.4
CPT0092440003	Tumor	-0.5
CPT0218770003	Tumor	-0.5
CPT0218960004	Tumor	-0.6
CPT0087680003	Tumor	-0.6
CPT0204340003	Normal	-0.6
CPT0204400003	Normal	-0.6
CPT0204360003	Normal	-0.7
CPT0189250003	Tumor	-0.7
CPT0104220003	Tumor	-0.7
CPT0218670003	Tumor	-0.7
CPT0204410003	Normal	-0.8
CPT0206330003	Tumor	-0.8
CPT0204420003	Normal	-0.8
CPT0204370003	Normal	-0.8
CPT0204380003	Normal	-0.8
CPT0224330003	Tumor	-0.9
CPT0199770003	Tumor	-0.9
CPT0190240004	Tumor	-0.9
CPT0204390003	Normal	-0.9
CPT0204330003	Normal	-1.0
CPT0104330003	Tumor	-1.1
CPT0204350003	Normal	-1.2
CPT0162140003	Tumor	-1.2
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA051702
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade